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Non-tuberculous mycobacteria (NTM) are not only emerging and opportunistic
pathogens of both humans and animals, but from a veterinary point of view some
species induce cross-reactive immune responses that hamper the diagnosis of bovine
tuberculosis (bTB) in both livestock and wildlife. Little information is available about NTM
species circulating in wildlife species of South Africa. In this study, we determined the
diversity of NTM isolated from wildlife species from South Africa as well as Botswana.
Thirty known NTM species and subspecies, as well as unidentified NTM, and NTM
closely related toMycobacterium goodii/Mycobacterium smegmatis were identified from
102 isolates cultured between the years 1998 and 2010, using a combination of
molecular assays viz PCR and sequencing of different Mycobacterial house-keeping
genes as well as single nucleotide polymorphism (SNP) analysis. The NTM identified
in this study include the following species which were isolated from tissue with
tuberculosis- like lesions in the absence ofMycobacterium tuberculosis complex (MTBC)
implying their potential role as pathogens of animals: Mycobacterium abscessus subsp.
bolletii,Mycobacterium gastri, Mycobacterium species closely related toMycobacterium
goodii/Mycobacterium smegmatis, Mycobacterium brasiliensis,Mycobacterium sinense
JMD 601, Mycobacterium avium subsp. avium, Mycobacterium sp. GR-2007,
Mycobacterium bouchedurhonense, and Mycobacterium septicum/M. peregrinum.
Mycobaterium brasiliensis, Mycobacterium gastri, Mycobacterium sp. GR-2007, and
a potential novel Mycobacterium species closely related to Mycobacterium goodii
were found for the first time in this study to be potential pathogens of animals.
Mycobacterium simiae was isolated from a sample originating from a tuberculin skin test
positive reactor, demonstrating its potential to elicit inappropriate immune responses in
animals that may interfere with diagnosis of tuberculosis by immunology.Mycobacterium
abscessus subsp. bolletti was the most frequently detected NTM identified in 37 of
the 102 isolates. Other NTM species were also isolated from animals not showing any
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pathological changes. Knowledge gained in this study contribute to the understanding
of NTM species circulating in wild animals in South Africa and the pathogenic potential
of certain species, whose role in disease causation need to be examined, as well as to
a certain extent the potential of M. simiae to hamper the diagnosis of bTB.
Keywords: non-tuberculous mycobacteria, South African wildlife, bovine tuberculosis, 16S rDNA sequencing,
immune responses, potential pathogens
INTRODUCTION
Non-tuberculous mycobacteria (NTM), otherwise known
as “mycobacteria other than tuberculosis” (MOTT) or
environmental mycobacteria (EM) are believed to be natural
inhabitants of the environment, found as saprophytes,
commensals, and symbionts in the ecosystem. Since their
clinical relevance was unknown, these bacteria have been
neglected for many years as they have always been recognized
as just environmental contaminants or colonizers (Covert
et al., 1999). It was only after the acquired immune deficiency
syndrome (AIDS) epidemic that NTM attracted abrupt attention
in certain countries (Gopinath and Singh, 2010). Finding
immune compromised hosts, especially with the emergence of
the AIDS pandemic, some NTM species are now recognized as
potential opportunistic pathogens of humans (Mirsaeidi et al.,
2014). However, other than a few known NTM pathogens of
animals, including the well-knownMycobacterium avium subsp.
paratuberculosis, the etiological agent of Johne’s disease and
other members of the Mycobacterium avium complex (MAC),
reports of animal diseases caused by NTM are few.
Currently there are more than 150 non-tuberculous
mycobacterial species listed in public databases and about a third
of them have been implicated in diseases of humans. (http://
www.bacterio.net; Botha et al., 2013). Because of the ubiquity
of NTM, human infections have been reported from most
geographic areas in the world and the geographical distribution
is thought to be regional (Martin-Casabona et al., 2004; van
Ingen et al., 2009). Mycobacterial diseases caused by NTM
have been classified as skin lesions, localized lymphadenitis,
TB-like pulmonary lesions and disseminated diseases (Primm
et al., 2004). By far the most notable opportunistic NTM
pathogens of animals and humans are the members of the
Mycobacterium avium complex (MAC) consisting of closely
related species and subspecies including Mycobacterium avium
subsp. avium, Mycobacterium avium subsp. paratuberculosis,
Mycobacterium avium subsp. hominissuis, Mycobacterium
intracellulare, Mycobacterium sylvaticum, Mycobacterium
colombiense, Mycobacterium bouchedurhonense, Mycobacterium
timonense, Mycobacterium chimaera, Mycobacterium arosiense,
Mycobacterium yongonense, and Mycobacterium marseillense
(Cayrou et al., 2010). Other common NTM species reported
to cause opportunistic mycobacterial diseases include
Mycobacterium kansasii, Mycobacterium marinum, and
Mycobacterium ulcerans. Animal infections by M. kansasii are
very rare (Botha et al., 2013). Infections by Mycobacterium
haemophilum, Mycobacterium szulgai, Mycobacterium
fortuitum, Mycobacterium chelonae, Mycobacterium
wolinskyi, Mycobacterium scrofulaceum, Mycobacterium
abscessus, Mycobacterium xenopi, Mycobacterium genavense,
Mycobacterium fortuitum, Mycobacterium porcicum,
Mycobacterium farcinogens, Mycobacterium senegalense, and
Mycobacterium genavense have also been reported in humans or
animals. These NTM species have been reported to be etiology
of mycobacterial diseases in humans and a wide range of animal
species including livestock, wildlife amphibians, fish, reptiles,
seals, birds, and rodents (Tortoli et al., 1998; Bercovier and
Vincent, 2001; Martin-Casabona et al., 2004; van Ingen et al.,
2008; Malama et al., 2014).
There are even fewer reports of NTM isolated from wildlife
in Africa. Studies on isolation of NTM from animal sources
have mainly focused on either livestock from slaughter houses
or on NTM that were coincidentally isolated from animal tissue,
including livestock and wildlife, while looking forMycobacterium
bovis (Kazwala et al., 1998; Tschopp et al., 2010). The extent of
NTM infection and distribution in African wildlife is therefore
largely unknown. In a study in Ethiopian cattle, Mycobacterium
nonchromogenicum was isolated as a predominant species (Berg
et al., 2009) while Mycobacterium terrae was isolated as a
frequently occurring species in Ethiopian wildlife (Tschopp et al.,
2010). A study from Chad foundM. nonchromogenicum together
with MAC andM. fortuitum to be common in humans and cattle
(Diguimbaye-Djaïbe et al., 2006). Mycobacterium terrae was
isolated from cattle in Tanzania (Kazwala et al., 1998; Cleaveland
et al., 2007). M. nonchromogenicum has also been detected in
small mammals and cattle in Tanzania (Durnez et al., 2011). A
recent study in Tanzania identifiedMycobacterium intracellulare,
Mycobacterium lentiflavum, Mycobacterium fortuitum, and
Mycobacterium chelonae-abscessus group as the most frequently
isolated NTM from humans and wildlife (Katale et al., 2014).
It should be noted that, isolation of NTM from an animal
source does not necessarily imply an active disease status.
Mycobacterium goodii was reported to have caused infection
in a hyena in South Africa as well as in African rodents
in Tanzania and M. kansasii has been isolated from wild
animal (Bercovier and Vincent, 2001; van Helden et al., 2009;
Durnez et al., 2011). M. farcinogenes and M. senegalense were
reported to be responsible for bovine farcy, pathology found
in Africa (Bercovier and Vincent, 2001). The environment is
also of interest as the source of NTM infections (van Ingen
et al., 2009). In Uganda, M. nonchromogenicum, M. fortuitum
complex, M. avium complex, and M. gordonae were identified
as most frequently detected species from environmental samples
(Kankya et al., 2011). A study in Zaire also identified M.
nonchromogenicum and M. terrae to be among the most
prevalent NTM species in the environment (Portaels, 1995). In
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South Africa the following NTM have been identified as most
occurring in different studies: Gcebe et al. (2013) have found the
following NTM to be frequently occurring in African buffaloes,
cattle and their environments: Mycobacterium terrae, M.
nonchromogenicum, M. vaccae/M. vanbaalenii, and unidentified
species closely related to Mycobacterium moriokense. They also
noted an overlap in terms of the species isolated from the
animal sources as well as the environments indicating that NTM
are readily exchanged between the environment and animals
(Gcebe et al., 2013). Botha et al. (2013) have reported isolation
of the following NTM from different wildlife species including
lions, rhinos, banded mongooses, cattle, baboons, elephants, and
monkeys: M. abcessus, M. asiaticum, M. avium, M. brasilienses,
M. chelonae, M. elephantis, M. engbackii, M. farcinogenes,
M. fortuitum, M. gilven, M. gordonae, M. heraklionense, M.
hiberniae, M. intracellulare, M. interjectum, M. lentiflavum,
M. marseillense, M. moriokaense, M. nonchromogenicum, M.
palustre, M. pulveris, M. paraffinicum, M. phlei, M. senegalense,
M. simiae, M. sherrisii, M. sphagni, M. terrae, and M. vulneris.
Mycobacterium gordonae and Mycobacterium gilvum were
identified as the most frequently occurring NTM in biofilms, in a
study by September et al. (2004).
In Africa, high interaction between wild animals especially
captive and semi-captive, the environment, and humans seem to
be very common posing a risk of NTM contamination of natural
waters and transmission of NTM between animals and humans
(Katale et al., 2014).
From a veterinary point of view, besides being opportunistic
pathogens, some NTM species may colonize the host without
development of any disease, but inappropriately prime the host’s
immune system hampering the immuno-diagnosis of bovine
tuberculosis by tuberculin based assays (Vordermeier et al.,
2007; Schiller et al., 2010). Furthermore, NTM may have a
negative effect on vaccination of animals byMycobacterium bovis
Bacillus Calmette-Guérin (BCG; Poyntz et al., 2014). Incidents
of bovine tuberculosis in different South African wildlife have
been reported, and efforts for eradication or reduction of the
diseases to minimal levels include the test and slaughter strategies
(Hlokwe et al., 2014). Vaccination is also a possibility. Yet very
little information is available on NTM circulating in wild animals
in South Africa. Since, bovine tuberculosis (bTB) is endemic
in South African wildlife conservation areas, specifically, in the
Kruger National Park, incidences of NTM infection of wildlife
may have been neglected probably due to the fact that focus has
been on bTB, and NTM infection may be last on the agenda or
perceived to be less important. The irony is that the interference
of NTM in the diagnosis of bTB as well is in vaccination by
BCG may hinder the bTB control/eradication efforts in wildlife
of South Africa.
In this study, we determined the diversity of NTM species
isolated from different wildlife species of South Africa and
Botswana.
This study forms the basis for understanding the diversity of
NTM species which are circulating in the South African wildlife
as well as potential pathogens of different animal species as well as
NTM that may have potentially induced in-appropriate immune
responses which interfered with the diagnosis of tuberculosis.
This information may hopefully aid in the efforts for control
of bovine tuberculosis in wildlife through development of
diagnostic assays and vaccination strategies.
MATERIALS AND METHODS
Ethics Statement
This work was carried out from samples submitted for routine
diagnostic purposes in the Tuberculosis laboratory: a Veterinary
Laboratory of South Africa approved by the Department of
Agriculture, Forestry, and Fisheries (DAFF) in compliance with
the requirements of the Animal Diseases act no. 35 of 1984 as
well as DAFF 001, 002, and 012 procedures.
Study Site
Isolates originating from samples collected for bovine
tuberculosis or mycobacterial routine diagnosis from the
Greater Kruger National Park (GKNP) complex, the National
Zoological Gardens (NZG) of South Africa, and four private
game reserves, were used in this study. The Greater Kruger
National Park complex consists of several game parks/reserves
and covers the area in the north east of South Africa, covering
19.485 km2. National Zoological Gardens of South Africa is
located in Pretoria, north of the Gauteng Province north east
of South Africa, covering 0.85 km2. Three of the private game
reserves are located in the Mpumalanga Province, east of South
Africa, and one is located in the Northern Cape Province, north
west of South Africa. Isolates from mongoose and wildcat from
Botswana were also included in the study.
Sample Collection from Wildlife
Samples were collected opportunistically from dead as well as
live animals. Dead animals included road kills, animals that
died from disease or old age and animals that were culled
for bTB confirmation after they tested positive on tuberculin
skin test (TST). One hundred and two (102) tissue samples
including bronchial, mesenteric, thoracic, peripheral, abdominal,
mammary, axial, popliteal, cranial, and head lymph nodes as well
as lungs, liver, testicles, heart, tonsils, bone marrow, ulna, nose,
bronchial washes, and elbow hygroma were collected between
the years 1998 and 2010. Information regarding the different
animal species sampled and their geographic origin is presented
in Table 1.
Pathological Examination and Culture
Tissue samples to be processed for mycobacterial isolation were
carefully examined macroscopically for formation of suspected
tuberculous-like lesions (visible). The presence or absence of
suspect bTB-like lesion was recorded for each sample.
All tissue samples were processed and cultured according to
standard laboratory procedures in a Class II biosafety cabinet
(Esco Technologies, South Africa) following biosafety guidelines
as described in the OIE Terrestrial manual (OIE, 2015). Briefly,
∼5 g of tissue samples were cut into small pieces and covered with
100 ml of sterile distilled water. The samples were homogenized
at 4500 rpm using the Ultra-Turrax R© homogenizer (Separation
Scientific, SA). Seven milliliters of the homogenates were poured
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TABLE 1 | Different wildlife species sampled and their geographic origin.
Animal species Total number of
animals sampled
Geographic origin
(n = number of samples)
Lion (n = 66) GKNP (n = 60)
Private game reserves in SA
(n = 6)
Leopard (n = 6) GKNP in SA (n = 4)
NZG in SA (n = 2)
Hyena (n = 4) GKNP in SA (n = 4)
White rhino (n = 2) Private game reserves in SA
(n = 2)
Eland (n = 2) Private game reserves in SA
(n = 2)
Vervet monkey (n = 2) Private game reserves in SA
(n = 2)
Black wildebeest (n = 2) Private game reserves in SA
(n = 2)
Cheetah (n = 1) GKNP in SA (n = 1)
Kudu (n = 1) GKNP in SA (n = 1)
Spotted genet (n = 1) Private game reserve in SA
(n = 1)
Meerkat (n = 1) Private game reserve in SA
(n = 1)
Orang-utan (n = 1) NZG in SA (n = 1)
Lichtenstein hartebeest (n = 1) GKNP in SA (n = 1)
Wild cat (n = 1) Botswana (n = 1)
Mongoose (n = 7) Botswana (n = 7)
Nyala (n = 1) GKNP in SA (n = 1)
Bushbuck (n = 1) GKNP in SA (n = 1)
African rodent (n = 1) NZG in SA (n = 1)
Blesbok (n = 1) GKNP in SA (n = 1)
into two separate 15 ml falcon tubes, and decontaminated with
7 ml of 2% HCl and 7 ml of 4% NaOH, respectively. The
suspensions were incubated at room temperature for 10 min
and centrifuged again. Following centrifugation, sterile distilled
water was added to the pellet. The pellet was inoculated onto
four Löwenstein-Jensen (LJ) media slopes supplemented with
pyruvate, as well as two slopes supplemented with glycerol and an
antibiotic cocktail of polymyxin B, ampho-tericin B, carbenicillin,
and trimethoprim (PACT) (National Health Laboratories, South
Africa, and Becton Dickinson, South Africa). The slopes were
incubated at 37◦C and monitored weekly for mycobacterial
growth. When growth of bacteria was observed, based on
morphology of mycobacterial colonies, individual colonies were
selected for Ziehl–Neelsen staining. The acid fast cultures were
stored at−21◦C for further analysis.
DNA Extraction
DNA was extracted using the heating method. Individual acid
fast colonies were suspended in 100 µl of sterile distilled water
and heated at 95◦C in a heating block/or in boiling water for 25
min. The culture suspensions were stored at−70 or−20◦C until
further analysis.
In vitro Amplification and Sequencing of
the Mycobacterial 16S rDNA and hsp65
Genes for NTM Speciation
PCR and sequencing of the 577 bp fragment of the mycobacterial
16S rDNAwas used for mycobacterial speciation (Harmsen et al.,
2003; Gcebe et al., 2013). Sequencing of the 439 bp hsp65 gene
fragment was done for differentiation of some NTM species with
similar, or identical 16S rRNA which could not be delineated
using the 16S rDNA PCR-sequencing assay (Telenti et al., 1993).
16S rDNA PCR
PCR targeting a 577 bp fragment of mycobacterial 16S rDNAwas
performed using the primers: 16S-F (5′-AGA GTT TGA TCM
TGGCTCAG-3′) and 16S-R (5′-GCGACAAACCACCTAAGA
G-3′). Culture suspensions were used as DNA template in a 25
µl PCR mixture containing 12.9 µl deionized water, 2.5 µl of
10X PCR buffer [160 mM; Tris Cl, KCl, (NH4)2SO4], 2 µl MgCl2
(25 mM), 1 µl dNTPs (10 mM), 0.1 µl Taq polymerase (Qiagen
Hotstar Taq, Whitehead Scientific, South Africa), 5 µl of 5x Q-
solution, 1 µl of each forward and reverse primers (50 pmol)
and 1–2 µl DNA template. The PCR cycling parameters were as
follows: initial denaturation at 95◦C for 15 min, followed by 35
cycles of denaturation at 95◦C for 30 s, annealing at 60◦C for 30
s, and elongation at 72◦C for 30 s and a final extension at 72◦C
for 10 min.
hsp65 PCR
Tb11 (5′-ACCAACGATGGTGTGTCCAT-3′) and Tb12 (5′-
CTTGTCGAACCGCATACCCT-3′) primers were used for the
amplification of the hsp65 gene fragment. A 50 µl PCR mixture
containing 28.5 µl de-ionized water, 3 µl MgCl2 (25 mM), 1
µl dNTP mix (10 mM), 4.75 µl of 10x PCR buffer (160 mM)
[Tris-HCl, MgCl2, Tween 20, (NH4)2,SO4], 0.75 µl Taq DNA
Polymerase (5 U/µl; SuperthermTM), 1 µl of each forward and
reverse primers (50 pmol) and 10 µl of DNA template was
assembled. The PCR cycling parameters were as follows: Forty-
five cycles of denaturation at 94◦C for 1 min, annealing at 60◦C
for 1 min, and elongation at 72◦C for 1 min and final extension
at 72◦C for 10 min.
The PCR products were sent to Inqaba Biotechnologies, South
Africa for sequencing of the forward 16S rDNA strands and
both hsp65 gene strands using an ABI sequencer. Sequences
were edited manually and pairwise alignments undertaken using
the BioEdit Sequence alignment editor (version 7.1.9) and
Molecular Evolutionary Genetics Analysis (MEGA) platform
(www.megasoftware.net; version 7; Kumar et al., submitted).
The sequences were analyzed on the NCBI BLAST platform for
species identification (https://blast.ncbi.nlm.nih.gov/Blast.cgi) by
megablast.
PCR for Detection of Mycobacterium
avium subsp. avium and Mycobacterium
avium subsp. paratuberculosis
To delineate between two members of MAC: i.e., M. avium
subspecies paratuberculosis and M. avium subsp. avium which
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could not be differentiated by the genus specific 16S rDNA-
sequencing assay, the MYCGEN-MYCAV PCR as described by
Wilton and Cousins (1992) as well as amplification of the IS900
of theM. avium subsp. paratuberculosis (Cousins et al., 1999) was
conducted in two separate PCR reactions using primers described
below:
MYCGEN-F (5′-AGAGTTTGATCCTGGCTCAG-3′),
MYCGEN-R (5′-TGCACACAGGCCACAAGGGA-3′) and
MYCAV (5′-ACCAGAAGACATGCGTCTTG- 3′) primers
were used for screening of the Mycobacterium avium
subspecies avium isolates as described by Wilton and Cousins
(1992). Briefly a 25 µl PCR mixture was prepared, containing
14 µl de-ionized water, 2 µl MgCl2 (25 mM), 1 µl dNTP mix
(10 mM), 1 µl of 10x PCR buffer [160 mM; Tris-HCl, MgCl2,
Tween 20, (NH4)2, SO4], 0.125 µl Taq DNA Polymerase (5
U/µl; SuperthermTM), 0.5 µl of each primer (50 pmol), and
5 µl of DNA template. The PCR cycling parameters were as
follows: Initial denaturation at 94◦C for 5 min, followed by 40
cycles of denaturation at 94◦C for 30 s, annealing at 62◦C for
3 min, and elongation at 75◦C for 3 min.
IS900 (P90) forward: 5′-GAAGGGTGTTCGGGGCCGTC-
3′ and IS900 (P91) reverse: 5′-GAGGTCGATCGCCCACGT
GAC-3′ primers were used for screening of the isolates forM.
avium subsp. paratuberculosis in 50 µl PCR reaction mixture
containing 28 µl de-ionized water, 3 µl MgCl2 (25 mM), 2
µl dNTP mix (10 mM), 5 µl of 10x PCR buffer [160 mM;
Tris -HCl, MgCl2, Tween 20, (NH4)2,SO4], 0.125 µl Taq DNA
Polymerase (5 U/µl; Hotstar), 1 µl of each primer (50 pmol),
and 10 µl of DNA template. The PCR cycling parameters
were as follows: Initial denaturation at 95◦C for 10 min,
followed by fifty cycles of denaturation at 95◦C for 1 min,
annealing at 65◦C for 75 s, and elongation at 72◦C for 3
min. This was followed by a final elongation at 72◦C for 10
min. Amplicons were analyzed by electrophoresis on a 1.5%
agarose gel.
Alignment of the 16S rDNA Sequences and
Phylogenetic Analysis
Multiple alignment of the part of the 16S rDNA sequences
from representative isolate of each species identified in the
study as well other NTM sequences (both slow and rapidly
growing) extracted from NCBI Nucleotide database (https://
www.ncbi.nlm.nih.gov/nuccore) was performed using MEGA
version 7.0 platform (Kumar et al., submitted). For phylogenetic
analysis the 16S rDNA sequences were first trimmed at both
the 5′ and the 3′ ends to encompass the most corresponding
gene fragment sequences of mycobacteria deposited in NCBI
Nucleotide database. Phylogenetic trees were constructed using
the neighbor-joiningmethod (Satou andNei, 1987) and validated
using themaximum composite likelihoodmethod. One thousand
bootstrap replicates were run and Nocardia farcinica was used as
an outgroup.
Since M. smegmatis and M. goodii have similar 16S rDNA
sequences, isolates belonging or closely related to these two
species were differentiated by single nucleotide polymorphism
(SNP) analysis of their 16S rDNA sequences (Figure 1; van
Helden et al., 2008). Alignment of part of the isolate’s 16S rDNA
as well as that ofM. goodii andM. smegmatis reference sequences
extracted fromNCBI Nucleotide (https://www.ncbi.nlm.nih.gov/
nuccore) database was also performed using MEGA version 7.
SNP identification was done manually.
RESULTS
The diversity of NTM species isolated from different wild animals
in South Africa is presented in Table 2. The 16S rDNA and
hsp65 gene sequence analysis revealed that, of 102 isolates
FIGURE 1 | Alignment of part of the 16S rDNA sequences of three isolates and those of the referenceM. goodii andM. smegmatis retrieved from NCBI
nucleotide database (https://www.ncbi.nlm.nih.gov/nucleotide/) demonstrating similarity between the isolates from leopard to M. goodii as well as
sequence differences between the isolates from hyena and lion to M. goodii and M. smegmatis. The 16S rDNA sequence from the lion was submitted to
Genbank database and the accession number is KX670576. The two arrows point to single nucleotide differences that exist between M. smegmatis and M. goodii are
in this part of the 16S rDNA.
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TABLE 2 | NTM species diversity in wildlife and associated pathological changes.
NTM species
identified (n)
Host species (n) Sample/tissue NTM isolated from Pathological changes observed
(positive/total)
M. fortuitum Meerkat (1) Tracheal flushing
Lion (5) Head, thoracic, bronchial, peripheral lymph node,
bronchial wash
TST positivity (3/5)
Co-infection of the animal with MTBC (5/5)
Tuberculosis-like lesions (0/5)
Mongoose (1) Testicles TST positivity (ND)
Co-infection of the animal with MTBC (0/1)
Tuberculosis-like lesions (0/1)
Geneta tigrina (1) Lung TST positivity (ND)
Co-infection of the animal with MTBC (0/1)
Tuberculosis-like lesions (0/1)
M. abscessus subsp. bolletii Lion (33) Bronchial LN, abdominal LN, mesenteric LN,
popliteal LN, thoracic LN, peripheral LN, mammary
LN, head LN, lung, axillary LN, bone marrow
TST positivity (ND)
Co-infection of the animal with MTBC (3/33)
Tuberculosis-like lesions (1/33)
Hyena (2) Head LN, thoracic LN TST positivity (ND)
Co-infection of the animal with MTBC (0/1)
Tuberculosis-like lesions (0/1)
Leopard (2) Head LN, peripheral LN TST positivity (ND)
Co-infection of the animal with MTBC (0/2)
Tuberculosis-like lesions (0/2)
M. gastri (1) Nyala (1) Mesenteric and bronchial LN TST positivity (ND)
Co-infection of the animal with MTBC (0/1)
Tuberculosis-like lesions (1/1)
M. fluoranthenivorans Lion (2) Head, mesenteric LN TST positivity (ND)
Co-infection of the animal with MTBC (2/2)
Tuberculosis-like lesions (0/2)
M.
acapulcensis/M. flavescence
Lion (1) Peripheral LN TST positivity (ND)
Co-infection of the animal with MTBC (0/1)
Tuberculosis-like lesions (0/1)
M. brasiliensis Blesbok (1) Lung and heart TST positivity (ND)
Co-infection of the animal with MTBC (1/1)
Tuberculosis-like lesions (1/1)
Mongoose (1) Testicles TST positivity (ND)
Co-infection of the animal with MTBC (0/1)
Tuberculosis-like lesions (0/1)
White rhino (1) Abdominal LN TST positivity (ND)
Co-infection of the animal with MTBC (1/1)
Tuberculosis-like lesions (0/1)
Lichtenstein hartebeest (1) Head LN TST positivity (ND)
Co-infection of the animal with MTBC (0/1)
Tuberculosis-like lesions (1/1)
Mycobacterium sp.
GR-2007
Lion (1) LN TST positivity (ND)
Co-infection of the animal with MTBC (0/1)
Tuberculosis-like lesions (1/1)
(Continued)
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TABLE 2 | Continued
NTM species
identified (n)
Host species (n) Sample/tissue NTM isolated from Pathological changes observed
(positive/total)
M. elephantis Lion (1) Cranial LN TST positivity (ND)
Co-infection of the animal with MTBC (0/1)
Tuberculosis-like lesions (0/1)
M. yongonense/
intracellulare/M. marseilense
Mongoose (1) Lung TST positivity (ND)
Co-infection of the animal with MTBC (0/1)
Tuberculosis-like lesions (0/1)
M. intracellulare Mongoose (1) Spleen TST positivity (ND)
Co-infection of the animal with MTBC (0/1)
Tuberculosis-like lesions (0/1)
Wild cat (1) LN TST positivity (ND)
Co-infection of the animal with MTBC (0/1)
Tuberculosis-like lesions (0/1)
M. rhodesiae Lion (1) Elbow hygroma TST positivity (ND)
Co-infection of the animal with MTBC (1/1)
Tuberculosis-like lesions (0/1)
M. simiae Cheetah (1) Peripheral LN TST positivity (ND)
Co-infection of the animal with MTBC (0/1)
Tuberculosis-like lesions (0/1)
Vervet monkey (1) Spleen TST positivity (1/1)
Co-infection of the animal with MTBC (0/1)
Tuberculosis-like lesions (0/1)
M. bouchedurhonense Eland (1) Bronchial LN TST positivity (ND)
Co-infection of the animal with MTBC (0/1)
Tuberculosis-like lesions (1/1)
Leopard (1) Head LN TST positivity (ND)
Co-infection of the animal with MTBC (0/1)
Tuberculosis-like lesions (0/1)
M. duvalii Lion (1) Peripheral LN TST positivity (ND)
Co-infection of the animal with MTBC (0/1)
Tuberculosis-like lesions (0/1)
M. peregrinum Orang-utan (1) Above ear swab TST positivity (ND)
Co-infection of the animal with MTBC (0/1)
Tuberculosis-like lesions (0/1)
Lion (1) Peripheral LN TST positivity (ND)
Co-infection of the animal with MTBC (0/1)
Tuberculosis-like lesions (0/1)
M. palustre Lion (1) Peripheral and abdominal LN pool TST positivity (ND)
Co-infection of the animal with MTBC (0/1)
Tuberculosis-like lesions (0/1)
Leopard (1) Lung and mesenteric LN TST positivity (ND)
Co-infection of the animal with MTBC (0/1)
Tuberculosis-like lesions (0/1)
(Continued)
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TABLE 2 | Continued
NTM species
identified (n)
Host species (n) Sample/tissue NTM isolated from Pathological changes observed
(positive/total)
M. avium subsp. avium Lion (2) Thoracic LN TST positivity (ND)
Co-infection of the animal with MTBC (0/2)
Tuberculosis-like lesions (0/2)
Eland (1) Bronchial LN TST positivity (ND)
Co-infection of the animal with MTBC (0/1)
Tuberculosis-like lesions (1/1)
Hyena (1) Peripheral LN TST positivity (ND)
Co-infection of the animal with MTBC (0/1)
Tuberculosis-like lesions (0/1)
African rodent (1) Lung TST positivity (ND)
Co-infection of the animal with MTBC (0/1)
Tuberculosis-like lesions (0/1)
M. goodii Leopard (1) Peripheral LN TST positivity (ND)
Co-infection of the animal with MTBC (0/1)
Tuberculosis-like lesions (0/1)
Mycobacterium closely
related to M.
goodii/M. smegmatis
Lion (1) Thoracic LN TST positivity (ND)
Co-infection of the animal with MTBC (0/1)
Tuberculosis-like lesions (1/1)
Hyena (1) Peripheral LN TST positivity (ND)
Co-infection of the animal with MTBC (1/1)
Tuberculosis-like lesions (0/1)
M. virginiense Lion (1) Thoracic LN TST positivity (ND)
Co-infection of the animal with MTBC (1/1)
Tuberculosis-like lesions (0/1)
M. vulneris Mongoose (1) Spleen TST positivity (ND)
Co-infection of the animal with MTBC (0/1)
Tuberculosis-like lesions (0/1)
White rhino (1) Pre-scapcular LN TST positivity (ND)
Co-infection of the animal with MTBC (0/1)
Tuberculosis-like lesions (0/1)
M. sherrisiii Lion (1) Mesenteric LN TST positivity (ND).
Co-infection of the animal with MTBC (0/1)
Tuberculosis-like lesions (0/1)
M. hecheshornense DSM
4428/M. sydneyiensis/M.
xenopi “Hyn”
Wue-TB939/99
Vervet monkey (1) Spleen TST positivity (ND)
Co-infection of the animal with MTBC (0/1)
Tuberculosis-like lesions (0/1)
M. parafortuitum Bush buck (1) Pre-scapcular LN TST positivity (ND)
Co-infection of the animal with MTBC (0/1)
Tuberculosis-like lesions (0/1)
M. porcinum Black wildebeest (1) Pooled Organs TST positivity (ND)
Co-infection of the animal with MTBC (0/1)
Tuberculosis-like lesions (0/1)
(Continued)
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TABLE 2 | Continued
NTM species
identified (n)
Host species (n) Sample/tissue NTM isolated from Pathological changes observed
(positive/total)
Lion (3) Thoracic LN, head LN, ulna attachment TST positivity (ND)
Co-infection of the animal with MTBC (0/3)
Tuberculosis-like lesions (0/3)
M. vaccae/M. vanbaalenii Lion (1) Head LN TST positivity (ND)
Co-infection of the animal with MTBC (1/1)
Tuberculosis-like lesions (0/1)
M. sp. NJB901/M.sp. B6.
10-23/M. sp.
NLA001000256/M. sp.
CST-8.2b/M. chelonae/M.
fuerth
Leopard (1) Lung TST positivity (ND)
Co-infection of the animal with MTBC (1/1)
Tuberculosis-like lesions (0/1)
Mycobacterium sp. WCM
7299
Mongoose (1) Liver TST positivity (ND)
Co-infection of the animal with MTBC (0/1)
Tuberculosis-like lesions (0/1)
Mycobacterium sp. GPK
1020
Mongoose (1) Nose TST positivity (ND)
Co-infection of the animal with MTBC (0/1)
Tuberculosis-like lesions (0/1)
M. sinense JMD601 Lion (4) Head LN, thoracic LN, retropharyngeal LN TST positivity (ND)
Co-infection of the animal with MTBC (0/4)
Tuberculosis-like lesions (1/4)
M. septicum/M. peregrinum Lion (1) Organ TST positivity (ND)
Co-infection of the animal with MTBC (0/1)
Tuberculosis-like lesions (1/1)
Black wildebeest (1) Peripheral LN TST positivity (ND)
Co-infection of the animal with MTBC (0/1)
Tuberculosis-like lesions (1/1)
Unidentified Mycobacterial
species
Lion (5) Lung, liver, head LN, popliteal LN, bronchial wash TST positivity (ND)
Co-infection of the animal with MTBC (0/5)
Tuberculosis-like lesions (0/5)
Kudu (1) LN TST positivity (ND)
Co-infection of the animal with MTBC (0/1)
Tuberculosis-like lesions (0/1)
MTBC, Mycobacterium tuberculosis complex; ND, Not determined.
analyzed, 96 belong to 30 known Mycobacterium species, two
belonged to a species closely related to Mycobacterium goodii
and M. smegmatis and six represented species that could not be
identified from the NCBI database (<95% identical to species in
NCBI databse). SNP analysis of part of the 16S rDNA of two
isolates closely related to M. goodii and M. smegmatis and M.
smegmatis ATCC 19420 and M. goodii ATCC 700504 reference
strains revealed differences between these two isolates and M.
goodii and M. smegmatis, suggesting that these are potentially
novel species. The 16S rDNA fragment sequence of one of the
isolate closely relatedM. goodii/M. smegmatis originating from a
lion sample with tuberculosis-like lesions was submitted to the
Genbank database (https://www.ncbi.nlm.nih.gov/genbank) and
the accession number is KX670576.
Of the 102 isolates analyzed, 37 (36.3%) were identified as
Mycobacterium abscessus subsp. bolletii by sequencing of both
16S rDNA and the hsp65 gene fragments. Thirty-three of the
37 isolates originated from lion samples, two from hyenas and
another two from leopards. The second most frequently isolated
species was M. fortuitum (n = 8) isolated from lions (n = 5),
meerkat (n = 1), geneta tigrina (n = 1), and mongoose (n =
1); followed by M. sinense JMD601 (n = 4) with all isolates
originating from lion samples; M. brasiliensis (n = 4) isolated
from blesbok (n = 1), mongoose (n = 1), white rhino (n = 1)
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and Lichtenstein hartebeest (n = 1); and finally M. porcinum (n
= 4) isolated from lions (n = 3) and a black wildebeest (n = 1).
The other NTM species were identified in low numbers of <4
and these include: M. goodii, M. gastri, M. fluoranthenivorans,
M. acapulcensis/M. flavescence, Mycobacterium sp. GR-2007, M.
elephantis, M. intracellulare, M. yongonense/intracellulare/M.
marseilense, M. rhodesiae, M. simiae, M. bouchedurhonense,
M. duvalii, M. peregrinum, M. palustre, M. avium subsp. avium,
M. virginiense, M. sherrisiii, M. vulneris, M. hecheshornense
DSM 4428/M. sydneyiensis/M. xenopi “Hyn” Wue-TB939/99,
M. parafortuitum, M. sp. NJB901/M.sp. B6. 10-23/M. sp.
NLA001000256/M. sp. CST-8.2b/M. chelonae/M. fuerth,
M. vaccae/M. vanbaalenii, Mycobacterium sp. WCM 7299,
Mycobacterium sp. GPK 1020, M. septicum/M. peregrinum, and
Mycobacterium species closely related toM. goodii/M. smegmatis.
Phylogenetic relatedness of the isolates representative of
each species identified in this study, and other Mycobacterium
species, based on the 16S rDNA sequences is illustrated by the
phylogenetic tree in Figure 2.
To investigate if the NTM species isolated could have
potentially caused tuberculous-like or cross-reactive immune
responses, records relating to pathological changes including
the formation of tuberculosis-like lesions and the tuberculin
skin test positivity of the animals were analyzed. Information
about whether more than one Mycobacterium species including
Mycobacterium tuberculosis complex (MTBC) or another NTM
were isolated from a single sample showing tuberculosis-like
lesion was analyzed in-order to eliminate the possibility or any
doubt or confusion about which mycobacterial species could
have potentially caused lesions. However, we did not investigate
other pathogens other than Mycobacteria as potential causes
of lesions, a move that could have strengthened findings of
certain NTM species identified in this study, as opportunistic
pathogens of animals. A similar analysis was done at animal
level (Investigating if isolation of more than one Mycobacterium
species from the same animal). Likewise, information about
isolation of more than one Mycobacterium species from the
TST positive reactors was also investigated for elimination of
any doubt about which mycobacteria could have elicited an
immune response. The summary of the data is presented in
Table 2.
Tuberculosis-like lesions were observed in the mesenteric
and bronchial lymph nodes of nyala; lung, heart and head
lymph node of blesbok, and haartebeest; bronchial lymph
nodes of an eland and a lion; retropharyngeal lymph nodes and
lung of lion. In all these cases, pure cultures of the following
NTM species or subspecies were isolated and no any other
mycobacterial species was isolated from the same animal
or sample: M. abscessus subsp. bolletii isolated from lion,
Mycobacterium gastri was isolated from nyala; Mycobacterium
brasiliensis from blesbok and hartebeest; Mycobacterium
avium subsp. avium from eland; Mycobacterium sp. GR-2007,
Mycobacterium sinense JMD601, Mycobacterium species closely
related Mycobacterium goodii/Mycobacterium smegmatis, and
Mycobacterium septicum/M. peregrinum were all isolated
from lions. Co-infection of the host animal species with M.
bovis/M. tuberculosis and the following NTM species was
observed:M. abscessus subspecies bolletii, M. fluoranthenivorans,
M. brasiliensis, M. rhodesiae, Mycobacterium species closely
related to M. goodii/M. smegmatis, M. virginiense, M. vaccae/M.
vanbaalenii and finally, M. sp. NJB901/M.sp. B6. 10-23/M.
sp. NLA001000256/M. sp. CST-8.2b/M. chelonae/M. fuerth in
different animal species as shown in Table 2.
A pure culture of Mycobacterium simiae was isolated from
TST positive reactor vervet monkey. No other mycobacterial
species was isolated from this animal. In other cases, where
NTM were isolated, there were either no visible lesions or no
information regarding TST (Table 2).
DISCUSSION
In this study 30 known NTM species, a species closely related
to Mycobacterium goodii and M. smegmatis (comprising of
two isolates) as well-unidentified species (comprising of six
isolates) were detected from 102 isolates originating from
wild animals in South Africa and Botswana, collected between
the years 1998 and 2010. These findings demonstrate a wide
diversity of NTM species circulating in the wildlife ecosystems
of Southern Africa. Furthermore, isolation of strains belonging
to unidentified species suggests the occurrence of a number
of uncharacterized potentially novel NTM species in wildlife.
In this study except for a species found to be closely related
to M. goodii and M. smegmatis, they were not associated with
any pathological changes in their hosts and as such, their roles
in causing diseases and in eliciting an immune response are
not fully known. With the use of a combination of molecular
assays viz sequencing of the 16S rDNA and the hsp65 genes as
well as SNP analysis of the 16S rDNA, screening of the isolates
for IS900 and Mycobacterium avium specific 16S rDNA gene
fragments, we were able to delineate closely related species as
well as identification of some NTM to subspecies level. The
NTM identified in this study comprise species of which data
for their clinical and veterinary significance have been reported
previously (known pathogens), which have been previously
described as opportunistic pathogens; as well as species that
have not been previously reported to cause any diseases. The
isolation of these NTM groups (known pathogens as well as
those whose pathogenicity has not been reported in animals)
from tissue samples with tuberculosis-like lesions in this study
suggests their potential role as sources of infection in those
particular animals. These include Mycobacterium abscessus
subsp. bolletii, Mycobacterium gastri, Mycobacterium closely
related to Mycobacterium goodii, Mycobacterium brasiliensis,
Mycobacterium sinense JMD 601, Mycobacterium avium
subsp. avium, Mycobacterium sp. GR-2007, Mycobacterium
septicum/M. peregrinum, andMycobacterium bouchedurhonense.
Mycobacterium abscessus subspecies bolletii together
with Mycobacterium abscessus subspecies abscessus and
Mycobacterium abscessus subspecies massiliense constitute
the Mycobacterium abscessus group. These rapidly growing
Mycobacteria (RGM) have been identified not only as sources
of pulmonary infections but as sources of nosocomial, skin
and soft tissue infections, osteoarticular infections as well as
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FIGURE 2 | Phylogenetic tree constructed using neighbor joining method, illustrating the genetic position of the isolates. The species that the isolates
were found to belong to are shown in parenthesis next to each isolate. Genbank accession numbers for the reference sequences are also shown in parenthesis. The
tree is based on the partial 16S rDNA gene sequences. The percentage of replicate trees in which the associated taxa clustered together in the bootstrap test (1000
replicates) are shown next to the branches. Nocardia farcinica was used as an out group sequence. Evolutionary analyses were conducted in MEGA7.
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disseminated diseases in humans (Viana-Niero et al., 2008;
Piersimoni and Scarparo, 2009; Zelazyn et al., 2009; Colombo
et al., 2012). Another significance of these NTM is their high
resistance to antibiotics (Nessar et al., 2012). The different
subspecies however differ from each other in their antibiotic
resistance profile (Nessar et al., 2012). Information on the
pathogenic role of Mycobacterium abscessus subspecies bolletii
in animals is still scarce. This is the first study to report M.
abscessus subspecies bolletii as a probable cause of lesions in a
peripheral lymph node of a lion in South Africa. Mycobacterium
abcessus has been isolated in various fish species and has been
described to cause diseases in humans (Bercovier and Vincent,
2001). In a study in Asia, M. abscessus was found to be the
second most clinically relevant NTM, after Mycobacterium
avium subsp. avium, responsible for pulmonary diseases
(Simons et al., 2011). M. abscessus has also been previously
reported in animals of South Africa, including wildlife, but
not necessarily as a cause of diseases (Botha et al., 2013; Gcebe
et al., 2013). In three other cases in this study, co-infection
with M. bovis and this NTM was observed in lions. Isolation
of M. abscessus subspecies bolletii together with M. bovis from
sample presenting tuberculosis-like lesions could indicate the
role of this NTM as an opportunistic pathogen. Contrary, to
what has been reported in wildlife NTM diversity studies in
Ethiopia, Tanzania, and buffaloes in South Africa, M. abscessus
subsp. bolletii was isolated most frequently in this study mainly
from lions (Tschopp et al., 2010; Gcebe et al., 2013; Katale et al.,
2014).
Only a few reports of Mycobacterium gastri as a cause
of disseminated and pulmonary mycobacteriosis diseases in
humans have been published (Velayati et al., 2005; Guerra
et al., 2008). Our study presents a first report of Mycobacterium
gastri isolation in South Africa from an animal species (nyala)
which presented tuberculosis -like lesions. Investigation of the
pathogenic role of this NTM in animals is therefore necessary.
Mycobacterium avium subspecies avium is a well-known
and mostly studied animal pathogen (Rastogi et al., 2001). We
isolated this species/subspecies from a bronchial lymph node
of an eland with lesions, confirming its status as an animal
pathogen. It was also isolated from four other animal samples:
hyena, African rodent, and two lions without any visible lesions.
Mycobacterium sinense JMD601 is a recently described
pathogenic NTM, first isolated from a human patient with
tuberculosis- like disease (Zhang et al., 2013). Rónai et al. (2016)
have reported isolation of this species from wild boar, fallow
deer, swine, and cattle fromHungary.We isolated this pathogenic
NTM from a lion which also showed tuberculosis-like lesions, as
well as three other lion samples with no apparent lesions.
Mycobacterium brasiliensis has been isolated from humans
before, but its clinical relevance is still largely unknown
(Chin’ombe et al., 2016). Reports of isolation of this species
from animals are scarce. In this study we isolated this species
from a Lichtenstein hartebeest head lymph node without MTBC,
presenting tuberculosis like-lesions, suggesting its pathogenic
potential in this animal species. This NTM was isolated in this
study from samples from three other animals namely, blesbok,
mongoose, and white rhino, showing no visible lesions. Botha
et al. (2013) have reported isolation of this NTM from wildlife
of South Africa. It is important to examination this NTM’s role in
disease causation in animals.
Mycobacterium bouchedurhonense was isolated in this study
from an eland bronchial lymph node, representing tuberculosis-
like lesions. This recently described member of MAC is being
reported for the first time in South African wildlife.
We have also isolated Mycobacterium sp. GR-2007 from
a lymph node of a lion with lesions. This is not a validly
published Mycobacterium species, and there are no reports of
its occurrence. However, its isolation from a lymph node with a
tuberculosis-like lesion may imply its pathogenic nature and the
need for further characterization of this NTM.
Mycobacterium goodii is a RGM species closely related to M.
smegmatis. Mycobacterium goodii was reported to have caused
infection in a hyena in South Africa as well as in African rodents
in Tanzania (van Helden et al., 2009; Durnez et al., 2011). We
identified a Mycobacterium species closely related to M. goodii
andM. smegmatis from a lion lymph node with tuberculosis-like
lesions. This NTM is not in the public databases and as such it
could be a potential novel NTM species and therefore needs to be
further characterized with a particular focus on its pathogenicity.
It has also been hypothesized that mycobacterial infections
do not necessarily need to be established and maintained
by animal species, colonization without casing disease may
be enough for development of immune responses. Some
NTM species, notably Mycobacterium kansasii, Mycobacterium
marinum, and M. fortuitum have been reported to induce
anti-mycobacterial immune responses that interfere with the
diagnosis of bovine tuberculosis either by TST or gamma
interferon tests (Vordermeier et al., 2007; Michel et al., 2011).
Mycobacterium simiae was isolated in this study from as
sample originating from a tuberculin skin test positive monkey,
demonstrating its potential to elicit inappropriate immune
responses in monkeys that may interfere with diagnosis of
tuberculosis by immunological tests (Schiller et al., 2010). It
may therefore be important to investigate the role of this
NTM in eliciting cross-reactive immune responses against
Mycobacterium bovis antigens. M. simiae has been reported to
cause diseases in monkeys not presenting any specific pathology
and has also been isolated from fish (Bercovier and Vincent,
2001). This species has previously been reported in cattle, African
buffaloes, and the environments in South Africa (Gcebe et al.,
2013). It has also been isolated from cattle and humans in
Tanzania and from the environment in Uganda (Kankya et al.,
2011; Katale et al., 2014).
We also identified other species that have been shown to be of
clinical significance in human mycobacterial diseases in several
studies, which in this study were isolated from specimen without
lesions. These notably include members of the Mycobacterium
avium complex: M. yongonense/intracellulare/M. marseilense,
M. intracellulare as well as M. sherrisii, Mycobacterium
porcinum, and M. virginiense. Mycobacterium sherrisii is a slow
growing emerging human Mycobacterial pathogen, particularly
isolated from HIV positive patients who may develop invasive
and disseminated mycobacteriosis diseases (van Ingen et al.,
2011). Botha et al. (2013) had reported isolation of this
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 12 January 2017 | Volume 7 | Article 15
Gcebe and Hlokwe Non-tuberculous Mycobacteria in South African Wildlife
Mycobacterium species from wild animals in South Africa
(Botha et al., 2013). Mycobacterium virginiense is a recently
described member of the M. terrae complex reported to
cause major tenosynovitis/osteomyelitis in humans (Vasireddy
et al., 2016). Here, this species was isolated from a lion co-
infected with M. bovis and its possible role as an opportunistic
pathogen of animals need to be investigated. We report
isolation of this Mycobacterium species for the first time in
animals in South Africa. Mycobacterium porcinum was first
isolated from porcine lymph nodes presenting tuberculosis-
like lymphadenitis (Tsukamura et al., 1983). In this study,
this species was isolated from lions and black wildebeest.
The relevance of the MAC species, viz M. yongonense/M.
marseilense/M. intracellulare in disease causation or possible
cross-reactivity withM. bovis antigens was not established in our
case. Mycobacterium yongonense is a recently described member
of MAC isolated from patients with pulmonary symptoms (Kim
et al., 2013) while M. intracellulare is a known pathogen of
humans (van Ingen et al., 2009). This MAC species has been
isolated from cattle in Tanzania, and Uganda as well as from
wildlife in South Africa (Kankya et al., 2011; Botha et al.,
2013; Katale et al., 2014). Other NTM species isolated in this
study from specimen not presenting tuberculosis-like lesions
include M. fortuitum, M. fluoranthenivorans, M. elephantis,
M. vulneris, M. rhodesiae, M. duvalii, M. peregrinum, M. palustre,
M. vaccae/M. vanbaalenii, M. parafortuitum, Mycobacterium sp.
WCM 7299, and Mycobacterium sp. GPK 1020. These NTM
have been isolated from animals as well the environment in
several studies (Bercovier and Vincent, 2001; Botha et al., 2013;
Gcebe et al., 2013, 2016; Katale et al., 2014). Mycobacterium
fortuitum andM. vulneris have both been found to be associated
with pulmonary infections in humans (Simons et al., 2011;
Hoefsloot et al., 2013). The role of these mycobacterial species
as causative agents of disease as well as their possible influence in
bovine tuberculosis diagnostics has not been established in this
study.
In conclusion, we have elucidated the diversity of NTM species
circulating in different wild animals in South Africa. Thirty
known NTM species/subspecies as well as unidentified NTM,
were detected in this study, of which nine were isolated from
animal specimen showing tuberculosis-like lesions, highlighting
the importance of these NTM as potential pathogens of animals.
In addition, isolation of unidentified NTM species, suggests the
occurrence of a number of uncharacterized potentially novel
NTM species in wildlife, whose roles are unknown. Isolation
of Mycobacterium simiae from a positive TST reactor vervet
monkey free of MTBC demonstrate this NTM species’ ability to
induce cross-reactive immune responses against MTBC antigens.
Mycobacterium abscesses subsp. bolletti was found to be the
most frequently occurring NTM, isolated mainly from lions.
Knowledge gained in this study contribute to the understanding
of NTM species circulating in wild animals in South Africa and
the pathogenic potential of certain species as well as to a certain
extent their potential to hamper bTB immunological diagnostic
assays.
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